Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 33 for “"5-ASA"”.

  1. Investigating the Use of 5-Aminosalicylic Acid for the Prevention of Sporadic Colorectal Carcinogenesis

    … later developing CRC. 5-Aminosalicylic acid (5-ASA) is used extensively in ulcerative colitis and importantly reduces colitis associated cancer risk. 5-ASA is well-tolerated with an excellent safety profile making it a potential candidate for sporadic CRC prevention. However, the mechanisms …

    bristol Repository record for Investigating the Use of 5-Aminosalicylic Acid for the Prevention of Sporadic Colorectal Carcinogenesis (opens in a new tab) Embargoed until 2027-09-29

  2. Investigating the Effect of 5-aminosalicylic Acid on Colorectal Tumour Cell Metabolism

    … adverse side effects. 5-aminosalicylic acid (5-ASA) is<br/>an ‘aspirin-like drug’ used clinically for the management of ulcerative colitis and <br/>importantly, is well-tolerated. 5-ASA is reported to reduce the risk of colitis-associated <br/>cancer and has shown promise for prevention of …

    bristol Repository record for Investigating the Effect of 5-aminosalicylic Acid on Colorectal Tumour Cell Metabolism (opens in a new tab) Download PDF for Investigating the Effect of 5-aminosalicylic Acid on Colorectal Tumour Cell Metabolism (opens in a new tab)

  3. DEVELOPMENT OF AN ORAL MULTIPLE-UNIT DOSAGE FORM CONTAINING A HIGH LOAD OF 5-AMINOSALICYLIC ACID

    … ACID Introduction 5-aminosalicylic acid (5-ASA) is the first-line drug therapy for mild to moderate acute exacerbations of IBD (Inflammatory Bowel Disease). 5-ASA is generally administered at the dosage regimen of 2.4 g/day, even though recent clinical trials have convincingly demonstrated …

    milano Repository record for DEVELOPMENT OF AN ORAL MULTIPLE-UNIT DOSAGE FORM CONTAINING A HIGH LOAD OF 5-AMINOSALICYLIC ACID (opens in a new tab)

  4. Investigation into the production of calcium pectinate particles for oral delivery to the colon

    … particles, loaded with 5 aminosalicylic acid (5-ASA) was explored. Their potential for controlled drug release to the colon was evaluated. Two production methods for the particles were explored; the ‘syringe droplet’ method and the ‘water in oil’ emulsion method. The characteristics of these …

    birmingham Download PDF for Investigation into the production of calcium pectinate particles for oral delivery to the colon (opens in a new tab)

  5. Atomic Layer Deposition for Personalized Drug Release Systems: 5-Aminosalicylic Acid as a Model Pharmaceutical

    … as a technique to coat 5-Aminosalicylic acid (5-ASA)—a drug to treat inflammatory bowel disease—to control 5-ASA's release throughout the gastrointestinal tract. 5-ASA was coated with 300 cycles of Al2O3 and 200 cycles ZnO ALD and was characterized by Fourier transform infrared spectroscopy …

    ucf Repository record for Atomic Layer Deposition for Personalized Drug Release Systems: 5-Aminosalicylic Acid as a Model Pharmaceutical (opens in a new tab)

  6. Preparation, development and evaluation of novel drug delivery systems for colon targeting

    … del colon: l’acido 5-amminosalicilico (5-ASA) e il metronidazolo (MTZ). Per la preparazione di questi sistemi sono stati scelti sistemi pH-dipendent ed enzima-dipendenti. Sistemi pH-dipendenti sono stati preparati con il 5-ASA. N-Succinyl-chitosano (SucCH) è stato usato come carrier …

    cagliari Repository record for Preparation, development and evaluation of novel drug delivery systems for colon targeting (opens in a new tab)

  7. ΠΡΟΣΔΙΟΡΙΣΜΟΣ ΤΩΝ ΠΑΡΑΓΩΓΩΝ ΤΟΥ ΑΡΑΧΙΔΟΝΙΚΟΥ ΟΞΕΟΣ ΣΕ ΦΛΕΓΜΟΝΩΔΗ ΝΟΣΗΜΑΤΑ ΤΟΥ ΕΝΤΕΡΟΥ

    … COLITIS, BEFORE AND AFTER TREATMENT WITH 5 - ASA 1,5 G ORALLY TAKEN EVERY DAY FOR 30 DAYS AND WERE COMPARED WITH RESULTS OF ELEVEN HEALTHY VOLUNTEERS. AFTER STATISTICAL ANALYSIS THE RESULTS CAN BE SUMMOND AS FOLLOWS: THE LEVEL OF PGE2 AND LTB4 IS HIGH IN THE TOTAL NUMBER OF PATIENTS AND …

    greece Repository record for ΠΡΟΣΔΙΟΡΙΣΜΟΣ ΤΩΝ ΠΑΡΑΓΩΓΩΝ ΤΟΥ ΑΡΑΧΙΔΟΝΙΚΟΥ ΟΞΕΟΣ ΣΕ ΦΛΕΓΜΟΝΩΔΗ ΝΟΣΗΜΑΤΑ ΤΟΥ ΕΝΤΕΡΟΥ (opens in a new tab)

  8. Μελέτη της επίδρασης χημειοπροφυλακτικών παραγόντων στην απόπτωση κυττάρων του κολονικού επιθηλίου

    … (COX)-2 inhibitors and 5-Amino-salicylate (5-ASA,) added alone or in combination with 5-fluorouracil (5-FU), on apoptosis and proliferation of 2 human colonic cancer cell lines (HT-29 and Caco-2) were the principal aims of the present study. Apoptosis was initially evaluated by …

    greece Repository record for Μελέτη της επίδρασης χημειοπροφυλακτικών παραγόντων στην απόπτωση κυττάρων του κολονικού επιθηλίου (opens in a new tab)

  9. The development of novel colon targeted drug delivery systems

    … To deliver 5-aminosalicylic acid (5-ASA) into the colon without any drug loss in stomach, spherical 5-ASA loaded zein nanoparticles (NPs) were prepared by nanoprecipitation in order to incorporate them into the HPMCAS fibers. Single-step particle-in-fiber incorporation by co-axial …

    east-anglia Download PDF for The development of novel colon targeted drug delivery systems (opens in a new tab)

  10. Micropartículas poliméricas à base de xilana e Eudragit® S-100 contendo mesalazina visando à liberação cólon-específica

    … molecule for the treatment of IBD, mesalazine (5-ASA) is rapidly absorbed in the upper gastrointestinal tract and its systemic absorption leads to risks of adverse effects. The aim of this work was to develop a microparticulate system based on xylan and Eudragit® S- 100 (ES100) for colon-specific …

    brazil-ufrn Repository record for Micropartículas poliméricas à base de xilana e Eudragit® S-100 contendo mesalazina visando à liberação cólon-específica (opens in a new tab)

  11. Micropartículas de xilana contendo mesalazina visando a liberação no cólon

    … mesalamine-loaded xylan microparticles (XMP5-ASA) by cross-linking polymerization using a non-hazardous cross-linking agent. The microparticles were characterized by thermal analysis (DSC/TG), X-ray diffraction (XRD), infrared spectroscopy (FTIR-ATR) and scanning electron microscopy (SEM). A …

    brazil-ufrn Repository record for Micropartículas de xilana contendo mesalazina visando a liberação no cólon (opens in a new tab)

  12. Azathioprin bei chronisch entzündlichen Darmerkrankungen

    … und Comedikation (Glukokortikosteroide und 5-ASA). Bei Patienten mit Morbus Crohn konnte in 31% der Fälle eine Remissionsinduktion mit Azathioprin erreicht werden. Die selbe Ansprechrate zeigte sich auch bei Patienten mit Colitis ulcerosa. Diese niedrige Ansprechrate ist wahrscheinlich auf die …

    lmu-germany Repository record for Azathioprin bei chronisch entzündlichen Darmerkrankungen (opens in a new tab)

  13. Mobile genetic elements in Campylobacter concisus and their clinical relevance in inflammatory bowel disease

    … anti-inflammatory drug 5-aminosalicylic acid (5-ASA) on the growth of C. concisus and other enteric microbes were investigated. AZA and MP significantly inhibited the growth of all 11 C. concisus strains. Interestingly, 5-ASA showed inhibitory effect on some C. concisus strains, while it promoted …

    unsw Repository record for Mobile genetic elements in Campylobacter concisus and their clinical relevance in inflammatory bowel disease (opens in a new tab)

  14. Development of 3D printed controlled drug delivery systems by dual Fused Deposition Modelling (FDM): Role of formulation and internal geometry on modulation of drug release

    … of the model drug 5-aminosalicylic acid (5-ASA) are introduced in Chapter I. Based on two model designs (Models 1 and 2), different formulations and geometries were chosen for each compartment. Regarding the formulation, hydroxypropyl methylcellulose acetate succinate (HPMCAS, HG and HMP …

    sevilla Repository record for Development of 3D printed controlled drug delivery systems by dual Fused Deposition Modelling (FDM): Role of formulation and internal geometry on modulation of drug release (opens in a new tab)

  15. Chemoprevention of colorectal cancer in inflammatory bowel diseases using routinely prescribed medications

    … studies using the ResearchOne database, 5-ASA medications (OR 0.32, 95% CI 0.23 to 0.45), immunomodulators (OR 0.49, 95% CI 0.31 to 0.79), NA-NSAIDs (OR 0.68, 95% CI 0.49 to 0.95), non-aspirin antiplatelets (OR 0.41, 95% CI 0.20 to 0.84), and statins (OR 0.55, 95% CI 0.37 to 0.81) were …

    whiterose Download PDF for Chemoprevention of colorectal cancer in inflammatory bowel diseases using routinely prescribed medications (opens in a new tab)

  16. Der frühe Morbus Crohn im Langzeitverlauf

    … Ein Alter > 40 Jahre sowie eine Therapie mit 5-ASA bei Erstdiagnose (p < 0,012) zeigte eine Assoziation zu milden Verläufen. Zudem konnte gezeigt werden, dass das Verhalten (Behaviour) in der Montreal-Klassifikation im Langzeitverlauf relativ stabil bleibt und dass das penetrierende / …

    cau-kiel Repository record for Der frühe Morbus Crohn im Langzeitverlauf (opens in a new tab)

  17. Μικροβίωμα και ιδιοπαθή φλεγμονώδη νοσήματα εντέρου

    … antibiotics. All of the adults received 5-ASA (± Azathioprine ± Cortisone) or Azathioprine. Using a sensitive reverse transcription–quantitative real-time PCR (RT-qPCR) method, we determined the composition of microbiota. NOD2/CARD15 genotyping, was also studied. Total bacterial DNA …

    greece Repository record for Μικροβίωμα και ιδιοπαθή φλεγμονώδη νοσήματα εντέρου (opens in a new tab)

  18. Retrospektive Analyse zum Vergleich des Einflusses einer frühen oder späten Intervention mit Tumornekrosefaktor-alpha-Antikörper-Therapie auf den Krankheitsverlauf bei Patienten mit Morbus Crohn

    … und waren seltener mit Steroiden (p=0,014), 5-ASA (p< 0,001) oder Azathioprin (p< 0,001) vorbehandelt. Zwei Jahre nach TNF-AK-Erstgabe unterschied sich der CDAI in den beiden Gruppen nicht (89,4% vs. 87,9%, p = 0,737). Aber innerhalb von 2 Jahren erreichten FI-Patienten eine höhere …

    lmu-germany Repository record for Retrospektive Analyse zum Vergleich des Einflusses einer frühen oder späten Intervention mit Tumornekrosefaktor-alpha-Antikörper-Therapie auf den Krankheitsverlauf bei Patienten mit Morbus Crohn (opens in a new tab)

  19. Pharmakokinetik von Olsalazin beim Pferd

    Pharmakokinetische Grundlagenuntersuchung nach oraler Applikation des Prodrugs Olsalazin im Hinblick auf dessen mögliche therapeutische Anwendung bei unspezifischen entzündlichen Dickdarmerkrankungen des Pferdes (z.B.Typhlokolitis).

    qucosa-diss

  20. Regulatory Elements of Polyphosphate Biosynthesis

    … inhibitor mesalamine (5-aminosalicylic acid, 5-ASA), a poor inhibitor of polyH-tagged PPK, was found to be more effective when tested on the C-tagged enzyme. Finally, subtle differences in the previously described PPK* mutant enzymes were identified that suggest that each mutation leads to …

    uab Repository record for Regulatory Elements of Polyphosphate Biosynthesis (opens in a new tab)

Page 1 of 2